Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder

Author(s): Benchalak Maneeton *, Narong Maneeton , Pakapan Woottiluk and Surinporn Likhitsathian

Volume 18, Issue 9, 2020

Page: [852 - 860] Pages: 9

DOI: 10.2174/1570159X18666200221113134

open access plus

Abstract

Objectives: The aims of this study were to systematically review the efficacy, acceptability, and tolerability of repetitive transcranial magnetic stimulation (rTMS) combined with antidepressants in the treatment of the first major depressive disorder (MDD) episode.

Materials and Methods: The primary efficacious outcome was the pooled mean-endpoint scores of the Hamilton Depression Rating Scale (HAMD). Rates of response, remission rate, overall discontinuation and discontinuation due to adverse events were also evaluated. Search in the Scopus, PubMed, CINAHL, and Cochrane Controlled Trials Register databases for interesting outcomes was carried out in March 2018.

Results: A total of 108 randomized patients of two randomized controlled trials were included in this study. The pooled mean- endpoint scores of the HAMD in one, two, and four weeks for rTMS plus antidepressants (citalopram or paroxetine) were greater than that of sham plus the antidepressants. The pooled rates of overall discontinuation and discontinuation rates due to adverse events were not different between the two groups.

Conclusion: According to a piece of limited evidence, the high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) could accelerate the antidepressant effect of SSRIs in young patients with a first-episode major depressive disorder. However, the acceptability and tolerability of HF-rTMS in the treatment of such patients are no better than an antidepressant alone. However, further well-defined and large sample-size studies of HF-rTMS combined with an antidepressant in MDD should be carried out to warrant these results.

Keywords: Citalopram, paroxetine, Hamilton depression rating scale, efficacy, acceptability, tolerability.

« Previous Next »
Graphical Abstract

[1]
Cohen, R.M.; Greenberg, J.M.; Ishak, W.W. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the individual burden of illness index for depression to measure treatment impact and recovery in mdd. JAMA Psychiatry, 2013, 70(3), 343-350.
[http://dx.doi.org/10.1001/jamapsychiatry.2013.286] [PMID: 23303512]
[2]
Cipriani, A.; Furukawa, T.A.; Salanti, G.; Chaimani, A.; Atkinson, L.Z.; Ogawa, Y.; Leucht, S.; Ruhe, H.G.; Turner, E.H.; Higgins, J.P.T.; Egger, M.; Takeshima, N.; Hayasaka, Y.; Imai, H.; Shinohara, K.; Tajika, A.; Ioannidis, J.P.A.; Geddes, J.R. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet, 2018, 391(10128), 1357-1366.
[http://dx.doi.org/10.1016/S0140-6736(17)32802-7] [PMID: 29477251]
[3]
Maneeton, B.; Maneeton, N.; Likhitsathian, S.; Woottiluk, P.; Wiriyacosol, P.; Boonyanaruthee, V.; Srisurapanont, M. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review. Neuropsychiatr. Dis. Treat., 2018, 14, 1953-1961.
[http://dx.doi.org/10.2147/NDT.S152410] [PMID: 30122927]
[4]
Frazer, A.; Benmansour, S. Delayed pharmacological effects of antidepressants. Mol. Psychiatry, 2002, 7(Suppl. 1), S23-S28.
[http://dx.doi.org/10.1038/SJ.MP.4001015] [PMID: 11986992]
[5]
Tylee, A.; Walters, P. Onset of action of antidepressants. BMJ, 2007, 334(7600), 911-912.
[http://dx.doi.org/10.1136/BMJ.39197.619190.80] [PMID: 17478791]
[6]
Montgomery, S.A.; Bech, P.; Blier, P.; Möller, H.J.; Nierenberg, A.A.; Pinder, R.M.; Quitkin, F.M.; Reimitz, P.E.; Rosenbaum, J.F.; Rush, A.J.; Stassen, H.H.; Thase, M.E. Selecting methodologies for the evaluation of differences in time to response between antidepressants. J. Clin. Psychiatry, 2002, 63(8), 694-699.
[http://dx.doi.org/10.4088/JCP.V63N0806] [PMID: 12197449]
[7]
Stahl, S.M.; Nierenberg, A.A.; Gorman, J.M. Evidence of early onset of antidepressant effect in randomized controlled trials. J. Clin. Psychiatry, 2001, 62(Suppl. 4), 17-23.
[PMID: 11229783]
[8]
Kasper, S.; Spadone, C.; Verpillat, P.; Angst, J. Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. Int. Clin. Psychopharmacol., 2006, 21(2), 105-110.
[http://dx.doi.org/10.1097/01.YIC.0000194375.42589.C3] [PMID: 16421462]
[9]
Bostwick, J.M.; Pankratz, V.S. Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry, 2000, 157(12), 1925-1932.
[http://dx.doi.org/10.1176/APPI.AJP.157.12.1925] [PMID: 11097952]
[10]
Berman, R.M.; Narasimhan, M.; Sanacora, G.; Miano, A.P.; Hoffman, R.E.; Hu, X.S.; Charney, D.S.; Boutros, N.N. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol. Psychiatry, 2000, 47(4), 332-337.
[http://dx.doi.org/10.1016/S0006-3223(99)00243-7] [PMID: 10686268]
[11]
Brunoni, A.R.; Chaimani, A.; Moffa, A.H.; Razza, L.B.; Gattaz, W.F.; Daskalakis, Z.J.; Carvalho, A.F. Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: a systematic review with network meta-analysis. JAMA Psychiatry, 2017, 74(2), 143-152.
[http://dx.doi.org/10.1001/JAMAPSYCHIATRY.2016.3644] [PMID: 28030740]
[12]
Teng, S.; Guo, Z.; Peng, H.; Xing, G.; Chen, H.; He, B.; Mcclure, M.A.; Mu, Q. High-frequency repetitive transcranial magnetic stimulation over the left dlpfc for major depression: session-dependent efficacy: a meta-analysis. Eur. Psychiatry, 2017, 41, 75-84.
[13]
Garcia-Toro, M.; Talavera, J.A.; Saiz-Ruiz, J.; Gonzalez, A. Prosody impairment in depression measured through acoustic analysis. J. Nerv. Ment. Dis., 2000, 188(12), 824-829.
[http://dx.doi.org/10.1097/00005053-200012000-00006] [PMID: 11191583]
[14]
Mosimann, U.P.; Schmitt, W.; Greenberg, B.D.; Kosel, M.; Müri, R.M.; Berkhoff, M.; Hess, C.W.; Fisch, H.U.; Schlaepfer, T.E. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Res., 2004, 126(2), 123-133.
[http://dx.doi.org/10.1016/j.psychres.2003.10.006] [PMID: 15123391]
[15]
Poulet, E.; Brunelin, J.; Boeuve, C.; Lerond, J.; D’Amato, T.; Dalery, J.; Saoud, M. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment. Eur. Psychiatry, 2004, 19(6), 382-383.
[16]
Rumi, D.O.; Gattaz, W.F.; Rigonatti, S.P.; Rosa, M.A.; Fregni, F.; Rosa, M.O.; Mansur, C.; Myczkowski, M.L.; Moreno, R.A.; Marcolin, M.A. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol. Psychiatry, 2005, 57(2), 162-166.
[http://dx.doi.org/10.1016/j.biopsych.2004.10.029] [PMID: 15652875]
[17]
Garcia-Toro, M.; Salva, J.; Daumal, J.; Andres, J.; Romera, M.; Lafau, O.; Echevarría, M.; Mestre, M.; Bosch, C.; Collado, C.; Ibarra, O.; Aguirre, I. High (20-hz) and low (1-hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res., 2006, 146(1), 53-57.
[http://dx.doi.org/10.1016/j.pscychresns.2004.08.005] [PMID: 16356697]
[18]
Bretlau, L.G.; Lunde, M.; Lindberg, L.; Undén, M.; Dissing, S.; Bech, P. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry, 2008, 41(2), 41-47.
[http://dx.doi.org/10.1055/S-2007-993210] [PMID: 18311683]
[19]
Hausmann, A.; Kemmler, G.; Walpoth, M.; Mechtcheriakov, S.; Kramer-Reinstadler, K.; Lechner, T.; Walch, T.; Deisenhammer, E.A.; Kofler, M.; Rupp, C.I.; Hinterhuber, H.; Conca, A. No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled “add on” trial. J. Neurol. Neurosurg. Psychiatry, 2004, 75(2), 320-322.
[PMID: 14742619]
[20]
Mogg, A.; Pluck, G.; Eranti, S.V.; Landau, S.; Purvis, R.; Brown, R.G.; Curtis, V.; Howard, R.; Philpot, M.; Mcloughlin, D.M. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression. Psychol. Med., 2008, 38(3), 323-333.
[http://dx.doi.org/10.1017/S0033291707001663] [PMID: 17935639]
[21]
Huang, M.L.; Luo, B.Y.; Hu, J.B.; Wang, S.S.; Zhou, W.H.; Wei, N.; Hu, S.H.; Xu, Y. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial. Aust. N. Z. J. Psychiatry, 2012, 46(3), 257-264.
[http://dx.doi.org/10.1177/0004867411433216] [PMID: 22391283]
[22]
Wang, Y.M.; Li, N.; Yang, L.L.; Song, M.; Shi, L.; Chen, W.H.; Li, S.X.; Wang, X.Y.; Lu, L. Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder. Psychiatry Res., 2017, 254, 18-23.
[http://dx.doi.org/10.1016/j.psychres.2017.04.005] [PMID: 28441583]
[23]
Higgins, J.P.T.; Altman, D.G. Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions. , Higgins, J.P.T.; Green , S., Eds.; , ; 2009.Version 5.1.0 (Updated March 2011) ed.: The Cochrane Collaboration; .
[24]
Cipriani, A.; Furukawa, T.A.; Salanti, G.; Geddes, J.R.; Higgins, J.P.; Churchill, R.; Watanabe, N.; Nakagawa, A.; Omori, I.M.; Mcguire, H.; Tansella, M.; Barbui, C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 2009, 373(9665), 746-758.
[http://dx.doi.org/10.1016/S0140-6736(09)60046-5] [PMID: 19185342]
[25]
Papakostas, G.I.; Homberger, C.H.; Fava, M. A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder. J. Psychopharmacol. (Oxford),, 2008, 22(8), 843-848.
[http://dx.doi.org/10.1177/0269881107083808] [PMID: 18308801]
[26]
Wiebe, N.; Vandermeer, B.; Platt, R.W.; Klassen, T.P.; Moher, D.; Barrowman, N.J. A systematic review identifies a lack of standardization in methods for handling missing variance data. J. Clin. Epidemiol., 2006, 59(4), 342-353.
[http://dx.doi.org/10.1016/j.jclinepi.2005.08.017] [PMID: 16549255]
[27]
Sterne, J.A.C.; Egger, M.; Moher, D. Addressing Reporting Biases. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (Updated March 2011) ed.: The Cochrane Collaboration; . 2009.http://www.cochrane-handbook.org
[28]
Aguirre, I.; Carretero, B.; Ibarra, O.; Kuhalainen, J.; Martínez, J.; Ferrer, A.; Salva, J.; Roca, M.; Gili, M.; Montoya, P.; Garcia-Toro, M. Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression. J. Affect. Disord., 2011, 130(3), 466-469.
[http://dx.doi.org/10.1016/j.jad.2010.10.038] [PMID: 21093060]
[29]
Bares, M.; Brunovsky, M.; Novak, T.; Kopecek, M.; Stopkova, P.; Sos, P.; Höschl, C. Qeeg theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine er in patients with major depressive disorder. Clin. eeg Neurosci., 2015, 46(2), 73-80.
[http://dx.doi.org/10.1177/1550059413520442] [PMID: 24711613]
[30]
Cevik, M.; Gunduz, C.; Tekin, A.; Karamustafalioglu, O. Sustained effects of repetitive transcranial magnetic stimulation in moderate to severe depression. Eur. Neuropsychopharmacol., 2015, 25, S440.
[http://dx.doi.org/10.1016/S0924-977X(15)30590-3]
[31]
Chi, C.T. The efficiency comparison of different-frequency repetitive transcranial magnetic stimulation combined with antidepressant drugs in patients with major depression,and the follow-up study used only drugs after rTMS treatment. http://appswhoint/ trialsearch/Trial2aspx?TrialID=ChiCTR-TRC-12001982 2012
[32]
Hansen, P.E.B.; Videbech, P.; Clemmensen, K.; Sturlason, R.; Jensen, H.M.; Vestergaard, P. Repetitive transcranial magnetic stimulation as add-on antidepressant treatment. the applicability of the method in a clinical setting. Nord. J. Psychiatry, 2004, 58(6), 455-457.
[http://dx.doi.org/10.1080/08039480410011678] [PMID: 16195088]
[33]
Herwig, U.; Fallgatter, A.J.; Höppner, J.; Eschweiler, G.W.; Kron, M.; Hajak, G.; Padberg, F.; Naderi-Heiden, A.; Abler, B.; Eichhammer, P.; Grossheinrich, N.; Hay, B.; Kammer, T.; Langguth, B.; Laske, C.; Plewnia, C.; Richter, M.M.; Schulz, M.; Unterecker, S.; Zinke, A.; Spitzer, M.; Schönfeldt-Lecuona, C. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br. J. Psychiatry, 2007, 191(NOV), 441-448.
[http://dx.doi.org/10.1192/bjp.bp.106.034371] [PMID: 17978325]
[34]
Rossini, D.; Lucca, A.; Magri, L.; Malaguti, A.; Smeraldi, E.; Colombo, C.; Zanardi, R. A symptom-specific analysis of the effect of high-frequency left or low-frequency right transcranial magnetic stimulation over the dorsolateral prefrontal cortex in major depression. Neuropsychobiology, 2010, 62(2), 91-97.
[http://dx.doi.org/10.1159/000315439] [PMID: 20523080]
[35]
Rossini, D.; Magri, L.; Lucca, A.; Giordani, S.; Smeraldi, E.; Zanardi, R. Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? a double-blind, randomized, sham-controlled trial. J. Clin. Psychiatry, 2005, 66(12), 1569-1575.
[http://dx.doi.org/10.4088/jcp.V66N1212] [PMID: 16401159]
[36]
Wang, H.; Xue, Y.; Chen, Y.; Zhang, R.; Wang, H.; Zhang, Y.; Gan, J.; Zhang, L.; Tan, Q. Efficacy of repetitive transcranial magnetic stimulation in the prevention of relapse of depression: study protocol for a randomized controlled trial. Trials, 2013, 14(1), 338.
[http://dx.doi.org/10.1186/1745-6215-14-338] [PMID: 24135054]
[37]
Wang, H.N.; Tan, Q.R.; Zhang, Z.J. Repetitive transcranial magnetic stimulation combined with venlafaxine for major depressive disorder with comorbid anxiety and insomnia: a controlled polysomnographic and diffusion mri study. Sleep Med., 2017, 40, E362
[http://dx.doi.org/10.1016/j.sleep.2017.11.1069]
[38]
Wang, H.N.; Wang, X.X.; Zhang, R.G.; Wan, Y.C.; Tan, Q.R.; Zhang, Z.J. REpetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: an assessor blind, randomized controlled trial. Brain Stimul., 2017, 10(2), 507-508.
[http://dx.doi.org/10.1016/j.brs.2017.01.482]
[39]
Wang, H.N.; Wang, X.X.; Zhang, R.G.; Wang, Y.; Cai, M.; Zhang, Y.H.; Sun, R.Z.; Guo, L.; Qiao, Y.T.; Liu, J.C.; He, H.; Wang, Z.H.; Wan, Y.C.; Tan, Q.R.; Zhang, Z.J. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Transl. Psychiatry, 2017, 7(12), 1292.
[http://dx.doi.org/10.1038/S41398-017-0001-X] [PMID: 29249805]
[40]
Chi, C.I. Event related potentials of transcranial magnetic stimulation combined with antidepressants in the treatment of major depressive disorder. http://appswhoint/trialsearch/Trial2aspx?TrialID=ChiCTRIOR- 160096722016
[41]
Loo, C.; Mcfarquhar, T.; Walter, G. Transcranial magnetic stimulation in adolescent depression. Australas. Psychiatry, 2006, 14(1), 81-85.
[42]
Mishra, B.R.; Sarkar, S.; Praharaj, S.K.; Mehta, V.S.; Diwedi, S.; Nizamie, S.H. Repetitive transcranial magnetic stimulation in psychiatry. Ann. Indian Acad. Neurol., 2011, 14(4), 245-251.
[http://dx.doi.org/10.4103/0972-2327.91935] [PMID: 22346010]
[43]
Mcgirr, A.; Van Den Eynde, F.; Tovar-Perdomo, S.; Fleck, M.P.; Berlim, M.T. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment resistant major depressive disorder: an open label trial. J. Affect. Disord., 2015, 173, 216-220.
[http://dx.doi.org/10.1016/j.jad.2014.10.068] [PMID: 25462419]
[44]
Berlim, M.T.; Van Den Eynde, F.; Daskalakis, Z.J. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J. Clin. Psychiatry, 2013, 74(2), E122-E129.
[http://dx.doi.org/10.4088/jcp.12R07996] [PMID: 23473357]
[45]
Boggio, P.S.; Fregni, F.; Bermpohl, F.; Mansur, C.G.; Rosa, M.; Rumi, D.O.; Barbosa, E.R.; Odebrecht Rosa, M.; Pascual-Leone, A.; Rigonatti, S.P.; Marcolin, M.A.; Araujo Silva, M.T. Effect of repetitive TMS and fluoxetine on cognitive function in patients with parkinson’s disease and concurrent depression. Mov. Disord., 2005, 20(9), 1178-1184.
[http://dx.doi.org/10.1002/mds.20508] [PMID: 15895421]
[46]
Liu, B.; Zhang, Y.; Zhang, L.; Li, L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry, 2014, 14, 342.
[http://dx.doi.org/10.1186/S12888-014-0342-4] [PMID: 25433539]
[47]
Valentine, J.C.; Pigott, T.D.; Rothstein, H.R. How many studies do you need? a primer on statistical power for meta-analysis. J. Educ. Behav. Stat., 2010, 35(3), 375-375.
[48]
Turner, R.M.; Bird, S.M.; Higgins, J.P. The impact of study size on meta-analyses: examination of underpowered studies in cochrane reviews. PLoS One, 2013, 8(3), e59202
[http://dx.doi.org/10.1371/journal.pone.0059202] [PMID: 23544056]
[49]
Mcclintock, S.M.; Reti, I.M.; Carpenter, L.L.; Mcdonald, W.M.; Dubin, M.; Taylor, S.F.; Cook, I.A.; O’Reardon, J.; Husain, M.M.; Wall, C.; Krystal, A.D.; Sampson, S.M.; Morales, O.; Nelson, B.G.; Latoussakis, V.; George, M.S.; Lisanby, S.H. National Network of Depression Centers rTMS Task Group; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments. Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J. Clin. Psychiatry,, 2018, 79(1) 1, 6cs10905.
[http://dx.doi.org/10.4088/JCP.16cs10905] [PMID: 28541649]

Rights & Permissions Print Cite
Article Metrics
47
1
World Autism Awareness Day
© 2024 Bentham Science Publishers | Privacy Policy